Tatar, B. Et Al. 2019. Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.. Revista da Associacao Medica Brasileira (1992) , vol.65 , 1470-1475.

Tatar, B., Köse, Ş., Ergun, N., Turken, M., Onlen, Y., Yılmaz, Y., ... Akhan, S.(2019). Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.. Revista da Associacao Medica Brasileira (1992) , vol.65, 1470-1475.

Tatar, B Et Al. "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.," Revista da Associacao Medica Brasileira (1992) , vol.65, 1470-1475, 2019

Tatar, B Et Al. "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.." Revista da Associacao Medica Brasileira (1992) , vol.65, pp.1470-1475, 2019

Tatar, B. Et Al. (2019) . "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.." Revista da Associacao Medica Brasileira (1992) , vol.65, pp.1470-1475.

@article{article, author={B Tatar Et Al. }, title={Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.}, journal={Revista da Associacao Medica Brasileira (1992)}, year=2019, pages={1470-1475} }